Literature DB >> 17459926

Predictable alphabeta T-cell receptor selection toward an HLA-B*3501-restricted human cytomegalovirus epitope.

Rebekah M Brennan1, John J Miles, Sharon L Silins, Melissa J Bell, Jacqueline M Burrows, Scott R Burrows.   

Abstract

Human cytomegalovirus (HCMV) elicits a very large burden on the immune system, with approximately one in ten T cells being reserved solely to manage this infection. However, information on the clonotypic composition of these vast T-cell populations is limited. In this study, we sequenced 116 T-cell receptor (TcR) alpha/beta-chains specific for the highly immunogenic HLA-B*3501-resticted epitope IPSINVHHY from the pp65 antigen. Interestingly, T cells recovered from all donors bore an identical or near-identical TRBV28/TRBJ1-4/TRAV17/TRAJ33 TcR. The ability to predict the responding alphabeta TcR repertoire before viral infection should prove a powerful tool for basic and clinical immunology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17459926      PMCID: PMC1933272          DOI: 10.1128/JVI.00356-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Junctional biases in the naive TCR repertoire control the CTL response to an immunodominant determinant of HSV-1.

Authors:  M E Wallace; M Bryden; S C Cose; R M Coles; T N Schumacher; A Brooks; F R Carbone
Journal:  Immunity       Date:  2000-05       Impact factor: 31.745

2.  Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study.

Authors:  J Olsson; A Wikby; B Johansson; S Löfgren; B O Nilsson; F G Ferguson
Journal:  Mech Ageing Dev       Date:  2000-12-20       Impact factor: 5.432

3.  Lack of prominent peptide-major histocompatibility complex features limits repertoire diversity in virus-specific CD8+ T cell populations.

Authors:  Stephen J Turner; Katherine Kedzierska; Helen Komodromou; Nicole L La Gruta; Michelle A Dunstone; Andrew I Webb; Richard Webby; Helen Walden; Wiedong Xie; James McCluskey; Anthony W Purcell; Jamie Rossjohn; Peter C Doherty
Journal:  Nat Immunol       Date:  2005-02-27       Impact factor: 25.606

4.  T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide.

Authors:  Fleur E Tynan; Scott R Burrows; Ashley M Buckle; Craig S Clements; Natalie A Borg; John J Miles; Travis Beddoe; James C Whisstock; Matthew C Wilce; Sharon L Silins; Jacqueline M Burrows; Lars Kjer-Nielsen; Lyudmila Kostenko; Anthony W Purcell; James McCluskey; Jamie Rossjohn
Journal:  Nat Immunol       Date:  2005-09-25       Impact factor: 25.606

5.  T cell control of primary and latent cytomegalovirus infections in healthy subjects.

Authors:  Anna K Lidehall; Fredrik Sund; Tobias Lundberg; Britt-Marie Eriksson; Thomas H Tötterman; Olle Korsgren
Journal:  J Clin Immunol       Date:  2005-09       Impact factor: 8.317

6.  T cell receptor recognition motifs govern immune escape patterns in acute SIV infection.

Authors:  David A Price; Sadie M West; Michael R Betts; Laura E Ruff; Jason M Brenchley; David R Ambrozak; Yvette Edghill-Smith; Marcelo J Kuroda; Derek Bogdan; Kevin Kunstman; Norman L Letvin; Genoveffa Franchini; Steven M Wolinsky; Richard A Koup; Daniel C Douek
Journal:  Immunity       Date:  2004-12       Impact factor: 31.745

7.  Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection.

Authors:  Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

8.  Selection of T cell clones expressing high-affinity public TCRs within Human cytomegalovirus-specific CD8 T cell responses.

Authors:  Lydie Trautmann; Marie Rimbert; Klara Echasserieau; Xavier Saulquin; Bérangère Neveu; Julie Dechanet; Vincenzo Cerundolo; Marc Bonneville
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

9.  Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects.

Authors:  Andrew W Sylwester; Bridget L Mitchell; John B Edgar; Cara Taormina; Christian Pelte; Franziska Ruchti; Paul R Sleath; Kenneth H Grabstein; Nancy A Hosken; Florian Kern; Jay A Nelson; Louis J Picker
Journal:  J Exp Med       Date:  2005-09-05       Impact factor: 14.307

10.  Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses.

Authors:  David A Price; Jason M Brenchley; Laura E Ruff; Michael R Betts; Brenna J Hill; Mario Roederer; Richard A Koup; Steven A Migueles; Emma Gostick; Linda Wooldridge; Andrew K Sewell; Mark Connors; Daniel C Douek
Journal:  J Exp Med       Date:  2005-11-14       Impact factor: 14.307

View more
  3 in total

1.  Immunosequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T cell repertoire.

Authors:  Ryan O Emerson; William S DeWitt; Marissa Vignali; Jenna Gravley; Joyce K Hu; Edward J Osborne; Cindy Desmarais; Mark Klinger; Christopher S Carlson; John A Hansen; Mark Rieder; Harlan S Robins
Journal:  Nat Genet       Date:  2017-04-03       Impact factor: 38.330

2.  Cytomegalovirus-specific CD8+ T cells targeting different peptide/HLA combinations demonstrate varying T-cell receptor diversity.

Authors:  Sandra Giest; Alasdair McWhinnie; Marie-Paule Lefranc; Ann-Margaret Little; Sarah Grace; Stephen Mackinnon; J Alejandro Madrigal; Paul J Travers
Journal:  Immunology       Date:  2012-01       Impact factor: 7.397

Review 3.  Individual response of humans to ionising radiation: governing factors and importance for radiological protection.

Authors:  K E Applegate; W Rühm; A Wojcik; M Bourguignon; A Brenner; K Hamasaki; T Imai; M Imaizumi; T Imaoka; S Kakinuma; T Kamada; N Nishimura; N Okonogi; K Ozasa; C E Rübe; A Sadakane; R Sakata; Y Shimada; K Yoshida; S Bouffler
Journal:  Radiat Environ Biophys       Date:  2020-03-07       Impact factor: 1.925

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.